These findings suggest that <i>TET2</i> mutations may drive clonal evolution and reprogram the tumor microenvironment, potentially facilitating divergent evolution from a common mutated precursor or the sequential development of distinct lymphoid neoplasms. Here, TET2 is linked to neoplasm.